Hyphens Pharma International Ltd: Digital healthcare catalyst emerges

Paul Chew

Head of Research @ PhillipCapital

Follow

6 June 2022

• Raised $6mn for a 10% stake in Hyphens Pharma digital assets – DocMed Technology

• DocMed Technology owns POM (B2B digital hypermart) and WellAway (Singapore’s first and only HSA registered e-pharmacy).

• Our DCF target price is raised from S$0.345 to S$0.43

Paul Chew

Head of Research @ PhillipCapital

Follow

6 June 2022

6 June 2022

Published byPhillipCapital

Share this report